These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 23998731)
61. Our experiences in treatment of patients suffering from rheumatoid arthritis. Mekić M; Ristić M Med Arh; 2008; 62(2):77-9. PubMed ID: 18669223 [TBL] [Abstract][Full Text] [Related]
65. Risks and benefits of low-dosage cyclosporin in rheumatoid arthritis. Pasero G; Ferraccioli GF; Portioli I BioDrugs; 1997 May; 7(5):376-85. PubMed ID: 18031101 [TBL] [Abstract][Full Text] [Related]
66. Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Collantes-Estevez E; Escudero-Contreras A; Pérez-Sánchez C Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260629 [TBL] [Abstract][Full Text] [Related]
67. [Gene transfer immunotherapy in rheumatoid arthritis: perspectives]. Jorgensen C Rev Med Interne; 2001 Feb; 22(2):163-71. PubMed ID: 11234674 [TBL] [Abstract][Full Text] [Related]
68. Rheumatoid arthritis--current trends in management. Wig N; Handa R; Aggarwal P; Wali JP Indian J Med Sci; 1997 Aug; 51(8):255-64. PubMed ID: 9491678 [TBL] [Abstract][Full Text] [Related]
69. Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer. Juarez M; Filer A; Buckley CD Swiss Med Wkly; 2012; 142():w13529. PubMed ID: 22367980 [TBL] [Abstract][Full Text] [Related]
70. [Observations on therapeutic action of gold salt in progressive chronic rheumatism]. BARWIK-SCHRAMM A Pol Arch Med Wewn; 1957; 27(8):1035-48. PubMed ID: 13505311 [No Abstract] [Full Text] [Related]
71. Rheumatoid arthritis--a review. Howe HS Ann Acad Med Singap; 1998 Jan; 27(1):83-8. PubMed ID: 9588280 [TBL] [Abstract][Full Text] [Related]
72. Gold salt therapy, minimal liver damage, and remission of rheumatoid arthritis. ARCHER BH N Y State J Med; 1952 Mar; 52(5):601-3. PubMed ID: 14899734 [No Abstract] [Full Text] [Related]
73. Rheumatoid arthritis: from palliation to remission in two decades. Brown PM; Isaacs JD Clin Med (Lond); 2014 Dec; 14 Suppl 6():s50-5. PubMed ID: 25468920 [TBL] [Abstract][Full Text] [Related]
74. The pathogenesis of rheumatoid arthritis. McInnes IB; Schett G N Engl J Med; 2011 Dec; 365(23):2205-19. PubMed ID: 22150039 [No Abstract] [Full Text] [Related]
75. Histopathology of the synovial tissue: perspectives for biomarker development in chronic inflammatory arthritides. Manzo A; Bugatti S; Caporali R; Montecucco C Reumatismo; 2018 Oct; 70(3):121-132. PubMed ID: 30282438 [TBL] [Abstract][Full Text] [Related]
76. Antibody engineering to develop new antirheumatic therapies. Isaacs JD Arthritis Res Ther; 2009; 11(3):225. PubMed ID: 19490600 [TBL] [Abstract][Full Text] [Related]
77. Management of rheumatoid arthritis: Impact and risks of various therapeutic approaches. Negrei C; Bojinca V; Balanescu A; Bojinca M; Baconi D; Spandidos DA; Tsatsakis AM; Stan M Exp Ther Med; 2016 Apr; 11(4):1177-1183. PubMed ID: 27073419 [TBL] [Abstract][Full Text] [Related]
78. Pleiotropic functions of plasmacytoid dendritic cells in the pathogenesis of the rheumatoid arthritis. Kupriyanov SV; Sinitskii AI Med Hypotheses; 2019 Jan; 122():26-30. PubMed ID: 30593416 [TBL] [Abstract][Full Text] [Related]